InvestorsHub Logo
Followers 743
Posts 62186
Boards Moderated 11
Alias Born 10/05/2009

Re: OPKOHEALTH2022 post# 14934

Wednesday, 05/12/2021 4:48:17 PM

Wednesday, May 12, 2021 4:48:17 PM

Post# of 15819
You lost me:

"OPK is reducing the amount of short shares and revenue over 1.5 billion most likely in 2021.and that is without the milestones payments from Somatrogon in the pipeline. "

I assume you increasing revenue? to over 1.5 Billion/year?

Shorts are covering on the dip?

Tell me about the millestone payments in the pipeline??? Please.

I got into OPK for Vit D-3 FDA EUA trial, and the chart dip bottom... and stayed for the massive turnaround confirmed in 3 financial filings driven by Covid19 Testing, which is only going to grow as the Sars Virus as more round planned, just at Taiwan and India, and the wake up call to test world wide and to use Vit D is only going to get louder.

I am tickled to score more shares down here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News